SlideShare a Scribd company logo
1 of 18
PRESENTATION ON
ESTIMATION OF ABSORPTION RATE CONSTANT
METHOD OF RESIDUALS
PRESENTED BY
DIVYA PUSHP
REG. NO.-VP21PHAR0100004
M. PHARM[PHARMACEUTICS]
INTRODUCTION
ABSORPTION-
• Absorption can be defined as the process of movement of unchanged drug from
site of administration to site of measurement i.e. plasma.
• The actual drug absorption process may be zero order, first order, or a combination
of rate processes that is not easily quantitated.
ABSORPTION RATE CONSTANT-
It may be defined as a value describing how much drug is absorbed per unit of time.
SIGNIFICANCE OF ABSORPTION RATE CONSTANT-
• For many immediate-release dosage forms, the absorption process is first-order
due to the physical nature of drug diffusion.
• The calculation of ka is useful in designing a multiple-dosage regimen.
• Knowledge of ka and k allows for the prediction of peak and trough plasma drug
concentrations following multiple dosing.
• In bio-equivalent studies, time of peak concentrations can be very useful in
comparing respective rates of absorption of a drug from chemically equivalent drug
products.
COMPARTMENT MODELS-
Compartmental modeling of pharmacokinetics describes the fate of a drug in the
body by dividing the whole body into one or more compartments. A compartment
involves several organs or tissues and is kinetically homogenous.
ONE COMPARTMENT OPEN MODEL
• Simplest form of model
• Depicts body as a single homogenous unit
TWO COMPARTMENT MODEL
• Divided the body into central and peripheral compartment.
• Central compartment (compartment 1)
- consists of the plasma and tissues
- where the distribution of the drug is practically instantaneous.
• The peripheral compartment (compartment 2)
-consists of tissues
- where the distribution of the drug is slower.
METHOD OF RESIDUALS
ONE COMPARTMENT MODEL
The technique is also known as feathering, peeling and stripping.
For a drug that follows one compartment kinetics and the time course of drug concentration in
plasma is expressed by a bi- exponential equation 1.
Equation 1 can be written as,
where, A is the hybrid comstant
During the elimination phase, when absorption is almost over,
Ka >>Ke and the value of second exponential
𝑒−𝐾𝑎𝑡approaches zero whereas the first exponential
𝑒−𝐾𝑒𝑡retains some finite value.
At this time the equation 2 reduces to
where C represents the back extrapolated plasma concentration
values.
Extrapolated plasma concentration- True plasma concentration i.e.,
equation 3 minus equation 2, gives residual concentration values
Plotting the Cr versus time should give another straight line graph with a slope equal
to -ka/2.303.
The value of ka is obtained by the following procedure:
1. Plot the drug concentration versus time on semi log paper with the concentration
values on the logarithmic axis.
2. Obtain the slope of the terminal phase (line BC,) by extrapolation.
3. Take any points on the upper part of line BC (eg, x′1, x′2, x′3, …) and drop vertically
to obtain corresponding points on the curve (eg, x1, x2,x3, …).
4. Read the concentration values at x1 and x′1, x2 and x′2, x3 and x′3, and so on. Plot
the values of the differences at the corresponding time points Δ1, Δ2, Δ3, … . A straight
line will be obtained with a slope of -ka/2.303.
Figure 4 Plasma level–time curve for a drug demonstrating first-order
absorption and elimination kinetics. The equation of the curve is
obtained by the method of residuals.
• When using the method of residuals, a minimum of three points
should be used to define the straight line.
• If drug absorption begins immediately after oral administration,
• In this method of calculation it is important to remember
that the following assumptions are made
It is assumed that ka is at least five times larger than kel, if
not neither constant can be determined accurately.
It is assumed that the absorption and elimination processes
both follow the first order, if not the residual line and,
perhaps, the elimination line will not be straight.
LAG TIME
In some individuals, absorption of drug after a single oral dose does not start immediately, due
to such physiologic factors as stomach-emptying time and intestinal motility.The time delay prior
to the commencement of the first order drug absorption is known as Lag time.
Figure 5 The lag time can be determined graphically if the two residual lines obtained
by feathering the plasma level–time curve intersect at a point where t > 0.
• Lag time should not be confused with onset time.
• The previous curve can be described by two equations:
In one, the lag time t0 is subtracted from each time point
This equation omits the lag time, as follows:
where A and B represent the intercepts on the y axis after extrapolation of the residual
lines for absorption and elimination, respectively.
The lag time, represents the beginning of drug absorption and should not be confused
with the pharmacologic term onset time, which represents latency, that is, the time
required for the drug to reach minimum effective concentration
FLIP FLOP OF ka AND kel
• The estimation of the rate constant for absorption and elimination by method of
residuals is based on the assumption that ka>>kel.
• If kel >>>> ka, then the values of k, from the terminal phase kel from the residual
line are obtained.
• This phenomenon is called flip-flop of the absorption and elimination rate constant.
• The only way to be sure of estimates is to compare Kel calculated from oral
administration with ka from intravenous data.
Figure 6 Flip-flop of ka and k.
• This technique works best when the difference between Ka and Kel is
large [Ka/Ke ≥ 3].
• In some instances, the Kel obtained after i.v. bolus of the same drug is
very large, much larger thean the Ka obtained by the method of
residuals [eg. Isoprenaline] and if Kel/Ka≥3 , then the terminal slope
estimates Ka and not Ke whereas the slope of the residual line gives
Ke and not Ka.
• This is called the flip-flop phenomenon since the slope of the two
lines have exchanged their meanings.
APPLICATIONS
• To calculate absorption rate constant for a drug administered orally ,absorbed by first
order kinetics and confer the characteristics of one and two compartment open model .
• This method is suited for drugs which are rapidly absorbed which are rapidly and
completely absorbed and follow one-compartment kinetics even when given i.v.
• This method enables resolution of the biexponential plasma level-time curve into its
two exponential components.
LIMITATIONS
• When the absorption is complex rather than a simple first order process.
• If the absorption of drug is affected in some way such as GI motility or enzymatic
degradation and if the drug shows multicompartment characteristics then the value of
ka that is obtained will be incorrect. Even if the drug is truly absorbed by first-order
kinetics.
THANK YOU

More Related Content

What's hot

Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kineticsSujit Patel
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailabilityshikha singh
 
P h partition hypothesis
P h partition hypothesisP h partition hypothesis
P h partition hypothesisZahid1392
 
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)DR. METI.BHARATH KUMAR
 
Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]Sagar Savale
 
Basic pharmacokinetics and compartment modelling
Basic pharmacokinetics  and compartment modellingBasic pharmacokinetics  and compartment modelling
Basic pharmacokinetics and compartment modellingPriyankaDabirBharadk
 
Application of pharmacokinetics
Application of pharmacokineticsApplication of pharmacokinetics
Application of pharmacokineticsChristy George
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing BioavailabilityDibrugarh University
 
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)DR. METI.BHARATH KUMAR
 
Techniques for enhancement of dissolution rate
Techniques for enhancement of dissolution rateTechniques for enhancement of dissolution rate
Techniques for enhancement of dissolution rateSagar Savale
 
In vitro Dissolution Testing Models
In vitro Dissolution Testing ModelsIn vitro Dissolution Testing Models
In vitro Dissolution Testing ModelsAmeer Ahmed
 
Methods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugsMethods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugsDebasish Ghadei
 
Methods for Measurement of bioavailability
Methods for Measurement of bioavailability Methods for Measurement of bioavailability
Methods for Measurement of bioavailability pharmacampus
 
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...DR. METI.BHARATH KUMAR
 
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolusPharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolusAreej Abu Hanieh
 

What's hot (20)

Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailability
 
P h partition hypothesis
P h partition hypothesisP h partition hypothesis
P h partition hypothesis
 
Non compartment model
Non compartment modelNon compartment model
Non compartment model
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
 
In-Vivo In-Vitro Correlation
In-Vivo In-Vitro CorrelationIn-Vivo In-Vitro Correlation
In-Vivo In-Vitro Correlation
 
Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
 
Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]
 
Basic pharmacokinetics and compartment modelling
Basic pharmacokinetics  and compartment modellingBasic pharmacokinetics  and compartment modelling
Basic pharmacokinetics and compartment modelling
 
Application of pharmacokinetics
Application of pharmacokineticsApplication of pharmacokinetics
Application of pharmacokinetics
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
 
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
 
Techniques for enhancement of dissolution rate
Techniques for enhancement of dissolution rateTechniques for enhancement of dissolution rate
Techniques for enhancement of dissolution rate
 
In vitro Dissolution Testing Models
In vitro Dissolution Testing ModelsIn vitro Dissolution Testing Models
In vitro Dissolution Testing Models
 
Methods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugsMethods of enhancing bioavailability of drugs
Methods of enhancing bioavailability of drugs
 
Methods for Measurement of bioavailability
Methods for Measurement of bioavailability Methods for Measurement of bioavailability
Methods for Measurement of bioavailability
 
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
 
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolusPharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
 

Similar to Estimation of Absorption Rate Constant Using Method of Residuals /TITLE

Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kineticsSuvarta Maru
 
Pharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionPharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionAreej Abu Hanieh
 
Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelDetermination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelAbhinayJha3
 
Determination of absorption and elimination rates on base of compartment model
 Determination of absorption and elimination rates on base of compartment model Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelAbhinayJha3
 
kinetics (Lec 1).pptx
kinetics (Lec 1).pptxkinetics (Lec 1).pptx
kinetics (Lec 1).pptxHebaYassin10
 
Week 4- the two open compartment
Week 4- the two open compartmentWeek 4- the two open compartment
Week 4- the two open compartmentlichlmh
 
NONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdfNONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdfKirti Goel
 
Concept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokineticConcept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokinetickavita bahmani
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacyemebetnigatu1
 
Non linear Pharmacokinetics 2
Non linear Pharmacokinetics 2Non linear Pharmacokinetics 2
Non linear Pharmacokinetics 2Areej Abu Hanieh
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokineticsShashi Yadav
 
Nonlinear pharmacokinetic
Nonlinear pharmacokineticNonlinear pharmacokinetic
Nonlinear pharmacokineticbuner12345
 
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptxCO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptxSamwel Samwel
 
Michaelis menten kinetics Nonlinear Pharmacokinetics
Michaelis menten kinetics Nonlinear PharmacokineticsMichaelis menten kinetics Nonlinear Pharmacokinetics
Michaelis menten kinetics Nonlinear PharmacokineticsSyed Umar Farooq
 
3.3 Multi compartment models.pptx
3.3 Multi compartment models.pptx3.3 Multi compartment models.pptx
3.3 Multi compartment models.pptxNeha Dand
 
anshu two compartment model 2.pptx
anshu two compartment model 2.pptxanshu two compartment model 2.pptx
anshu two compartment model 2.pptxAnshulvishwakarma10
 
IV-Bolus-and-Infusion.ppt
IV-Bolus-and-Infusion.pptIV-Bolus-and-Infusion.ppt
IV-Bolus-and-Infusion.pptNoorelhuda2
 

Similar to Estimation of Absorption Rate Constant Using Method of Residuals /TITLE (20)

Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
Pharmacokinetics of Oral Drug Absorption
Pharmacokinetics of Oral Drug AbsorptionPharmacokinetics of Oral Drug Absorption
Pharmacokinetics of Oral Drug Absorption
 
Pharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionPharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorption
 
Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment modelDetermination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment model
 
Determination of absorption and elimination rates on base of compartment model
 Determination of absorption and elimination rates on base of compartment model Determination of absorption and elimination rates on base of compartment model
Determination of absorption and elimination rates on base of compartment model
 
kinetics (Lec 1).pptx
kinetics (Lec 1).pptxkinetics (Lec 1).pptx
kinetics (Lec 1).pptx
 
Week 4- the two open compartment
Week 4- the two open compartmentWeek 4- the two open compartment
Week 4- the two open compartment
 
NONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdfNONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdf
 
Concept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokineticConcept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokinetic
 
multiple-dosage-regimen.pdf
multiple-dosage-regimen.pdfmultiple-dosage-regimen.pdf
multiple-dosage-regimen.pdf
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacy
 
Non linear Pharmacokinetics 2
Non linear Pharmacokinetics 2Non linear Pharmacokinetics 2
Non linear Pharmacokinetics 2
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
Nonlinear pharmacokinetic
Nonlinear pharmacokineticNonlinear pharmacokinetic
Nonlinear pharmacokinetic
 
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptxCO1_L10_ Introduction to Pharmacology and Therapeutics  Part 3.pptx
CO1_L10_ Introduction to Pharmacology and Therapeutics Part 3.pptx
 
Michaelis menten kinetics Nonlinear Pharmacokinetics
Michaelis menten kinetics Nonlinear PharmacokineticsMichaelis menten kinetics Nonlinear Pharmacokinetics
Michaelis menten kinetics Nonlinear Pharmacokinetics
 
3.3 Multi compartment models.pptx
3.3 Multi compartment models.pptx3.3 Multi compartment models.pptx
3.3 Multi compartment models.pptx
 
anshu two compartment model 2.pptx
anshu two compartment model 2.pptxanshu two compartment model 2.pptx
anshu two compartment model 2.pptx
 
Ppt of nayyer sir copy
Ppt of nayyer sir   copyPpt of nayyer sir   copy
Ppt of nayyer sir copy
 
IV-Bolus-and-Infusion.ppt
IV-Bolus-and-Infusion.pptIV-Bolus-and-Infusion.ppt
IV-Bolus-and-Infusion.ppt
 

More from Divya Pushp

METAL NANOPARTICLES
METAL NANOPARTICLESMETAL NANOPARTICLES
METAL NANOPARTICLESDivya Pushp
 
ANTIMICROBIAL AGENTS USED AS PRESERVATIVES.pptx
ANTIMICROBIAL AGENTS USED AS PRESERVATIVES.pptxANTIMICROBIAL AGENTS USED AS PRESERVATIVES.pptx
ANTIMICROBIAL AGENTS USED AS PRESERVATIVES.pptxDivya Pushp
 
REVIEW OF GUIDELINES FOR HERBAL COSMETICS BY PRIVATE BODIES LIKE COSMOS WITH ...
REVIEW OF GUIDELINES FOR HERBAL COSMETICS BY PRIVATE BODIES LIKE COSMOS WITH ...REVIEW OF GUIDELINES FOR HERBAL COSMETICS BY PRIVATE BODIES LIKE COSMOS WITH ...
REVIEW OF GUIDELINES FOR HERBAL COSMETICS BY PRIVATE BODIES LIKE COSMOS WITH ...Divya Pushp
 
Evaluation of protein and peptide formulations.pptx
Evaluation of protein and peptide formulations.pptxEvaluation of protein and peptide formulations.pptx
Evaluation of protein and peptide formulations.pptxDivya Pushp
 
ICH guidelines on impurities in new drug products.pptx
ICH guidelines on impurities in new drug products.pptxICH guidelines on impurities in new drug products.pptx
ICH guidelines on impurities in new drug products.pptxDivya Pushp
 
MECHANISTIC - ACAT.pptx
MECHANISTIC - ACAT.pptxMECHANISTIC - ACAT.pptx
MECHANISTIC - ACAT.pptxDivya Pushp
 
Regulatory requirements of row countries
Regulatory requirements of row countriesRegulatory requirements of row countries
Regulatory requirements of row countriesDivya Pushp
 

More from Divya Pushp (7)

METAL NANOPARTICLES
METAL NANOPARTICLESMETAL NANOPARTICLES
METAL NANOPARTICLES
 
ANTIMICROBIAL AGENTS USED AS PRESERVATIVES.pptx
ANTIMICROBIAL AGENTS USED AS PRESERVATIVES.pptxANTIMICROBIAL AGENTS USED AS PRESERVATIVES.pptx
ANTIMICROBIAL AGENTS USED AS PRESERVATIVES.pptx
 
REVIEW OF GUIDELINES FOR HERBAL COSMETICS BY PRIVATE BODIES LIKE COSMOS WITH ...
REVIEW OF GUIDELINES FOR HERBAL COSMETICS BY PRIVATE BODIES LIKE COSMOS WITH ...REVIEW OF GUIDELINES FOR HERBAL COSMETICS BY PRIVATE BODIES LIKE COSMOS WITH ...
REVIEW OF GUIDELINES FOR HERBAL COSMETICS BY PRIVATE BODIES LIKE COSMOS WITH ...
 
Evaluation of protein and peptide formulations.pptx
Evaluation of protein and peptide formulations.pptxEvaluation of protein and peptide formulations.pptx
Evaluation of protein and peptide formulations.pptx
 
ICH guidelines on impurities in new drug products.pptx
ICH guidelines on impurities in new drug products.pptxICH guidelines on impurities in new drug products.pptx
ICH guidelines on impurities in new drug products.pptx
 
MECHANISTIC - ACAT.pptx
MECHANISTIC - ACAT.pptxMECHANISTIC - ACAT.pptx
MECHANISTIC - ACAT.pptx
 
Regulatory requirements of row countries
Regulatory requirements of row countriesRegulatory requirements of row countries
Regulatory requirements of row countries
 

Recently uploaded

Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersSabitha Banu
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
ROOT CAUSE ANALYSIS PowerPoint Presentation
ROOT CAUSE ANALYSIS PowerPoint PresentationROOT CAUSE ANALYSIS PowerPoint Presentation
ROOT CAUSE ANALYSIS PowerPoint PresentationAadityaSharma884161
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfphamnguyenenglishnb
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Jisc
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxChelloAnnAsuncion2
 
Planning a health career 4th Quarter.pptx
Planning a health career 4th Quarter.pptxPlanning a health career 4th Quarter.pptx
Planning a health career 4th Quarter.pptxLigayaBacuel1
 
Quarter 4 Peace-education.pptx Catch Up Friday
Quarter 4 Peace-education.pptx Catch Up FridayQuarter 4 Peace-education.pptx Catch Up Friday
Quarter 4 Peace-education.pptx Catch Up FridayMakMakNepo
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
Atmosphere science 7 quarter 4 .........
Atmosphere science 7 quarter 4 .........Atmosphere science 7 quarter 4 .........
Atmosphere science 7 quarter 4 .........LeaCamillePacle
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomnelietumpap1
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 

Recently uploaded (20)

Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginners
 
Rapple "Scholarly Communications and the Sustainable Development Goals"
Rapple "Scholarly Communications and the Sustainable Development Goals"Rapple "Scholarly Communications and the Sustainable Development Goals"
Rapple "Scholarly Communications and the Sustainable Development Goals"
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
ROOT CAUSE ANALYSIS PowerPoint Presentation
ROOT CAUSE ANALYSIS PowerPoint PresentationROOT CAUSE ANALYSIS PowerPoint Presentation
ROOT CAUSE ANALYSIS PowerPoint Presentation
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
 
Planning a health career 4th Quarter.pptx
Planning a health career 4th Quarter.pptxPlanning a health career 4th Quarter.pptx
Planning a health career 4th Quarter.pptx
 
Quarter 4 Peace-education.pptx Catch Up Friday
Quarter 4 Peace-education.pptx Catch Up FridayQuarter 4 Peace-education.pptx Catch Up Friday
Quarter 4 Peace-education.pptx Catch Up Friday
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
Atmosphere science 7 quarter 4 .........
Atmosphere science 7 quarter 4 .........Atmosphere science 7 quarter 4 .........
Atmosphere science 7 quarter 4 .........
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choom
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 

Estimation of Absorption Rate Constant Using Method of Residuals /TITLE

  • 1. PRESENTATION ON ESTIMATION OF ABSORPTION RATE CONSTANT METHOD OF RESIDUALS PRESENTED BY DIVYA PUSHP REG. NO.-VP21PHAR0100004 M. PHARM[PHARMACEUTICS]
  • 2. INTRODUCTION ABSORPTION- • Absorption can be defined as the process of movement of unchanged drug from site of administration to site of measurement i.e. plasma. • The actual drug absorption process may be zero order, first order, or a combination of rate processes that is not easily quantitated. ABSORPTION RATE CONSTANT- It may be defined as a value describing how much drug is absorbed per unit of time. SIGNIFICANCE OF ABSORPTION RATE CONSTANT- • For many immediate-release dosage forms, the absorption process is first-order due to the physical nature of drug diffusion. • The calculation of ka is useful in designing a multiple-dosage regimen. • Knowledge of ka and k allows for the prediction of peak and trough plasma drug concentrations following multiple dosing. • In bio-equivalent studies, time of peak concentrations can be very useful in comparing respective rates of absorption of a drug from chemically equivalent drug products.
  • 3. COMPARTMENT MODELS- Compartmental modeling of pharmacokinetics describes the fate of a drug in the body by dividing the whole body into one or more compartments. A compartment involves several organs or tissues and is kinetically homogenous. ONE COMPARTMENT OPEN MODEL • Simplest form of model • Depicts body as a single homogenous unit TWO COMPARTMENT MODEL • Divided the body into central and peripheral compartment. • Central compartment (compartment 1) - consists of the plasma and tissues - where the distribution of the drug is practically instantaneous. • The peripheral compartment (compartment 2) -consists of tissues - where the distribution of the drug is slower.
  • 4. METHOD OF RESIDUALS ONE COMPARTMENT MODEL The technique is also known as feathering, peeling and stripping. For a drug that follows one compartment kinetics and the time course of drug concentration in plasma is expressed by a bi- exponential equation 1. Equation 1 can be written as, where, A is the hybrid comstant
  • 5.
  • 6.
  • 7. During the elimination phase, when absorption is almost over, Ka >>Ke and the value of second exponential 𝑒−𝐾𝑎𝑡approaches zero whereas the first exponential 𝑒−𝐾𝑒𝑡retains some finite value. At this time the equation 2 reduces to where C represents the back extrapolated plasma concentration values.
  • 8. Extrapolated plasma concentration- True plasma concentration i.e., equation 3 minus equation 2, gives residual concentration values
  • 9. Plotting the Cr versus time should give another straight line graph with a slope equal to -ka/2.303. The value of ka is obtained by the following procedure: 1. Plot the drug concentration versus time on semi log paper with the concentration values on the logarithmic axis. 2. Obtain the slope of the terminal phase (line BC,) by extrapolation. 3. Take any points on the upper part of line BC (eg, x′1, x′2, x′3, …) and drop vertically to obtain corresponding points on the curve (eg, x1, x2,x3, …). 4. Read the concentration values at x1 and x′1, x2 and x′2, x3 and x′3, and so on. Plot the values of the differences at the corresponding time points Δ1, Δ2, Δ3, … . A straight line will be obtained with a slope of -ka/2.303.
  • 10. Figure 4 Plasma level–time curve for a drug demonstrating first-order absorption and elimination kinetics. The equation of the curve is obtained by the method of residuals.
  • 11. • When using the method of residuals, a minimum of three points should be used to define the straight line. • If drug absorption begins immediately after oral administration,
  • 12. • In this method of calculation it is important to remember that the following assumptions are made It is assumed that ka is at least five times larger than kel, if not neither constant can be determined accurately. It is assumed that the absorption and elimination processes both follow the first order, if not the residual line and, perhaps, the elimination line will not be straight.
  • 13. LAG TIME In some individuals, absorption of drug after a single oral dose does not start immediately, due to such physiologic factors as stomach-emptying time and intestinal motility.The time delay prior to the commencement of the first order drug absorption is known as Lag time. Figure 5 The lag time can be determined graphically if the two residual lines obtained by feathering the plasma level–time curve intersect at a point where t > 0.
  • 14. • Lag time should not be confused with onset time. • The previous curve can be described by two equations: In one, the lag time t0 is subtracted from each time point This equation omits the lag time, as follows: where A and B represent the intercepts on the y axis after extrapolation of the residual lines for absorption and elimination, respectively. The lag time, represents the beginning of drug absorption and should not be confused with the pharmacologic term onset time, which represents latency, that is, the time required for the drug to reach minimum effective concentration
  • 15. FLIP FLOP OF ka AND kel • The estimation of the rate constant for absorption and elimination by method of residuals is based on the assumption that ka>>kel. • If kel >>>> ka, then the values of k, from the terminal phase kel from the residual line are obtained. • This phenomenon is called flip-flop of the absorption and elimination rate constant. • The only way to be sure of estimates is to compare Kel calculated from oral administration with ka from intravenous data. Figure 6 Flip-flop of ka and k.
  • 16. • This technique works best when the difference between Ka and Kel is large [Ka/Ke ≥ 3]. • In some instances, the Kel obtained after i.v. bolus of the same drug is very large, much larger thean the Ka obtained by the method of residuals [eg. Isoprenaline] and if Kel/Ka≥3 , then the terminal slope estimates Ka and not Ke whereas the slope of the residual line gives Ke and not Ka. • This is called the flip-flop phenomenon since the slope of the two lines have exchanged their meanings.
  • 17. APPLICATIONS • To calculate absorption rate constant for a drug administered orally ,absorbed by first order kinetics and confer the characteristics of one and two compartment open model . • This method is suited for drugs which are rapidly absorbed which are rapidly and completely absorbed and follow one-compartment kinetics even when given i.v. • This method enables resolution of the biexponential plasma level-time curve into its two exponential components. LIMITATIONS • When the absorption is complex rather than a simple first order process. • If the absorption of drug is affected in some way such as GI motility or enzymatic degradation and if the drug shows multicompartment characteristics then the value of ka that is obtained will be incorrect. Even if the drug is truly absorbed by first-order kinetics.

Editor's Notes

  1. Refer Leon Shargel Page number 189
  2. In some individuals, absorption of drug after a single oral dose does not start immediately, due to such physiologic factors as stomach-emptying time and intestinal motility
  3. The lag time, represents the beginning of drug absorption and should not be confused with the pharmacologic term onset time, which represents latency, that is, the time required for the drug to reach minimum effective concentration
  4. LEON SHARGEL